WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006084353) STABILIZED COMPOSITIONS FOR TOPICAL ADMINISTRATION AND METHODS OF MAKING SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/084353    International Application No.:    PCT/CA2006/000167
Publication Date: 17.08.2006 International Filing Date: 08.02.2006
IPC:
A61K 38/48 (2006.01), A61Q 19/00 (2006.01), A61K 47/42 (2006.01), A61K 31/728 (2006.01), A61K 38/39 (2006.01)
Applicants: DPM THERAPEUTICS CORP. [CA/CA]; 1016C Sutton Drive, Unit #8, Burlington, Ontario L7L 6B8 (CA) (For All Designated States Except US).
MODI, Pankaj [CA/CA]; (CA) (For US Only)
Inventors: MODI, Pankaj; (CA)
Agent: MCGUINNESS, Ursula; Gowling Lafleur Henderson LLP, 1 Main Street West, Hamilton, Ontario L8P 4Z5 (CA)
Priority Data:
11/057,481 14.02.2005 US
2,494,473 14.02.2005 CA
11/259,778 27.10.2005 US
Title (EN) STABILIZED COMPOSITIONS FOR TOPICAL ADMINISTRATION AND METHODS OF MAKING SAME
(FR) PRÉPARATIONS STABILISÉES POUR ADMINISTRATION LOCALE ET MÉTHODES D'ÉLABORATION DESDITES PRÉPARATIONS
Abstract: front page image
(EN)A stabilizing composition that also enhances permeation is provided for the topical or transdermal administration of an active ingredient. The composition preferably comprises collagen, elastin, sphingoside and cerebroside. Also provided are pharmaceutical or cosmetic formulations comprising an effective amount of an active agent and the stabilizing composition as well as methods of administering active agents topically or transdermally.
(FR)La présente invention porte sur une préparation stabilisante augmentant également la perméation, et destinée à l'administration locale ou transdermique d'un principe actif. Ladite préparation comprend préférentiellement du collagène, de l'élastine, du sphingoside et du cérébroside. La présente invention porte également sur des formules pharmaceutiques ou cosmétiques comprenant une quantité active d’un principe actif ainsi que la préparation stabilisante, de même que des méthodes d'administration de principes actifs par voie locale ou transdermique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)